Viewing Study NCT02728934


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-01-27 @ 8:09 AM
Study NCT ID: NCT02728934
Status: COMPLETED
Last Update Posted: 2020-04-15
First Post: 2016-03-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis
Sponsor: Janssen Scientific Affairs, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arthritis, Rheumatoid View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rheumatoid Arthritis View
None Golimumab View
None Infliximab View